AKSITINIB-MILI-1
Zapytaj lekarza o receptę na AKSITINIB-MILI-1
Jak stosować AKSITINIB-MILI-1
INSTRUCTIONS for medical use of the medicinal product CALENDULA OINTMENT (Unguentum Calendulae)
Composition
active substance: calendula tincture; 1 g of ointment contains 0.1 g of calendula tincture; excipients: white soft paraffin, purified water, emulsifier T-2.
Pharmaceutical form
Ointment.
Main physical and chemical properties
Ointment of yellowish color.
Pharmacotherapeutic group
Preparations that promote wound healing. ATC code D03A X.
Pharmacological properties
Pharmacodynamics
Calendula ointment contains flavonoids, carotenoids, saponins, tannins, organic acids, and other compounds. It has antiseptic, anti-inflammatory, and reparative properties.
Clinical characteristics
Indications
Burns, cuts, skin cracks, purulent wounds.
Contraindications
Increased individual sensitivity to the components of the preparation.
Interaction with other medicinal products and other types of interactions
Not established.
Special instructions
Should not be used by individuals prone to allergic reactions to calendula preparations. Avoid getting the ointment in the eyes. If the ointment accidentally gets into the eyes, they should be rinsed with water and medical attention should be sought immediately.
Use during pregnancy or breastfeeding
The safety and clinical efficacy of the preparation during pregnancy or breastfeeding have not been studied, so it is not recommended to prescribe it to this category of patients.
Ability to affect reaction speed when driving vehicles or operating other mechanisms
Does not affect.
Method of application and dosage
The ointment should be applied in a thin layer to the affected areas (can be used under an occlusive dressing). The duration of the treatment course is determined by the doctor individually and depends on the nature and severity of the pathological process or the achieved effect.
Children
The safety and efficacy of the ointment in children under 12 years of age have not been established, so the preparation can be used in this category of patients only after a careful assessment of the risk/benefit ratio (as prescribed by a doctor).
Overdose
Not detected. Possible enhancement of adverse reaction symptoms.
Adverse reactions
In case of increased individual sensitivity, allergic reactions may occur, including skin redness, rash, itching, angioedema.
Shelf life
2 years 6 months.
Storage conditions
Store in the original packaging at a temperature not exceeding 25 °C; freezing is not allowed. Store in a place inaccessible to children.
Packaging
40 g in containers, 20 g or 30 g in aluminum or laminated tubes.
1 tube in a pack or without a pack.
Release category
Without a prescription.
Manufacturer
Viola Pharmaceutical Factory, PrJSC.
Manufacturer's location and address of its business activity
69063, Ukraine, Zaporizhzhia, Akademika Amosova Street, 75.
Applicant
Viola Pharmaceutical Factory, PrJSC.
Applicant's location
69063, Ukraine, Zaporizhzhia, Akademika Amosova Street, 75.
- Kraj rejestracji
- Wymaga receptyTak
- Producent
- Te informacje mają charakter wyłącznie poglądowy i nie stanowią porady medycznej. Przed zastosowaniem jakiegokolwiek leku zawsze skonsultuj się z lekarzem. Oladoctor nie ponosi odpowiedzialności za decyzje medyczne podjęte na podstawie tych treści.
Lekarze online w sprawie AKSITINIB-MILI-1
Konsultacja w sprawie dawkowania, działań niepożądanych, interakcji, przeciwwskazań i odnowienia recepty na AKSITINIB-MILI-1 – decyzja należy do lekarza, zgodnie z lokalnymi przepisami.
Zapisz się na aktualizacje
Otrzymuj informacje o nowych usługach online, zmianach i ofertach dostępnych na Oladoctor w Europie.
